BACKGROUND INFORMATION REGARDING "BENEFAKTORINDEX" AND "BENEFAKTORZERTIFIKAT"
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
May 2021 ADVERTISING / PUBLIC
OFFERING ONLY IN CH
FOR D PLEASE REFER TO
BACKGROUND INFO
IN GERMAN.
Advertising: This publication constitutes advertising within the meaning of article 68 FinSA.
It serves only for information purposes and is not research.
It may be subject to change at any time without previous notice.
Background information regarding
„BeneFaktorIndex®“ and „BeneFaktorZerti kat®“
© Daubenthaler & Cie. GmbH
What are BeneFaktorIndex® and BeneFaktorZerti kat® - and what are they for?
Each BeneFaktorIndex® addresses a socially relevant, future related topic and the associated
BeneFaktorZerti kat® is the product that investors can purchase. Topics include all tomorrow’s topics: From
big topics concerning everybody (such as basic human rights, environmental protection, animal welfare and
nature conservation, mobility concepts), to more individualistic topics like lifestyle, sports, culture and much
more.
BeneFaktorZerti kat® are open-ended index tracker certi cates based on an existing index
(BeneFaktorIndex®) and they are always dedicated to a socially relevant and future oriented topic. 10% of
their annual fees are dedicated to support a non-pro t organization that e ectively implements the same
socially conscious values. BeneFaktorIndex® are mission conform, meaning investors can rest assured that
they are investing in a fair and reputable cause not only with a donation* but in the support of a mission
conform initiative.
Investing strictly with the mission in mind is called mission conform or impact investing. To put it plainly,
impact investments are designed to yield, in addition to nancial return, positive and quantitative change in
the social and environmental sectors. A BeneFaktorZerti kat® allows investors to make a twofold
contribution with one simple investment decision.
They directly combine both impact investing (mission conform) and philanthropy (automatic donations*).
This unique and obviously simple combination makes them the worlds rst “benefactor certi cates” or
“donation certi cates” within the nancial industry.
* Note: Donations are being given freely and on a voluntary basis, there are no underlying contracts or other binding
arrangements with the bene ciaries.
Issue: May 2021 Page 1 / 5 Daubenthaler & Cie. GmbH
fi
fi
fi
fi
fi
fi
fi
fi
fi
fi
fi
fi
ff
fi
May 2021 ADVERTISING / PUBLIC
OFFERING ONLY IN CH
FOR D PLEASE REFER TO
BACKGROUND INFO
IN GERMAN.
„BeneFaktor-Zerti kat® democratise philanthropy and impact investing.“
Philanthropy and impact investing are both terms used to describe the planned and systematically executed
act of furthering a good cause. Systematic giving is called „philanthropy“ whereas systematically investing in
a mission-aligned way is called „impact investing“. Historically, both approaches have been available only to
very wealthy individuals. The BeneFaktorZerti kat® is changing that. Now philanthropy and impact investing
are possible for everybody.
How is a BeneFaktorIndex® being allocated?
First of all, and as basic as this might sound, it has to be clear that any investor should be able to
understand their investments and, why they become part of their investment portfolio.
In order to achieve this, apart from expecting everyone to become extremely pro cient in nancial a airs,
there is the simple option of making an investment that actually is easy to understand. What is the most
important aspect that makes a nancial product „understandable“? It has to be transparent and how it
works must be logical. This is why each BeneFaktorIndex® has a clear set of individual rules - each has its
own set of rules, according to their purpose. These rules safeguard the bespoke nature and strict mission
alignment of each BeneFaktorIndex®. They also make sure only shares of companies who are t for this
particular purpose are being chosen. So, as a result of following a transparent and logical approach,
following clear rules according to each purpose, the result is a BeneFaktorIndex®.
It is fair to say that BeneFaktor-products are straightforward investment products. There are no hidden
caveats or strange leverage practices. What you see is what you get - a no frills investment product
dedicated to the common good and a speci c cause.
Issue: May 2021 Page 2 / 5 Daubenthaler & Cie. GmbH
fi
fi
fi
fi
fi
fi
fi
ff
May 2021 ADVERTISING / PUBLIC
OFFERING ONLY IN CH
FOR D PLEASE REFER TO
BACKGROUND INFO
IN GERMAN.
The selection of a speci c corporate stock for any BeneFaktorIndex® can only be accepted into the
BeneFaktorIndex® when it is either proven or it can be reasonably assumed that the company either
addresses or provides a solution for or avoids the issue named in the title of the BeneFaktorIndex®. Some
stocks are selected because the corporation is seriously pursuing solutions for a problem while others are
selected because the corporation avoids the whole issue altogether and nds alternative, i.e. better, ways to
deal with it. The selection of speci c stocks rests, in a high degree, on the dedication companies show in
ameliorating a certain issue and how big their relative contribution towards a better future is.
For example: A cosmetic company has many brands. One of the brands is free of animal cruelty. This
doesn’t make the whole company free from animal cruelty.
Or: A cosmetic company does not conduct animal tests, but commissions other companies for that. Said
corporation only purchases and uses the results of animal testing. This also does not make the company
free from animal cruelty and obviates them being selected for the „BeneFaktorIndex® NO ANIMAL
TESTING“. - This unique approach cannot be stressed enough, since by today’s standard best-in-class-
approach many such companies would probably be considered appropriate, owing to the fact that many
other companies conduct animal tests themselves while this particular contestant „only“ purchases them.
Genuinely animal-cruelty-free companies do not conduct animal tests nor do they commission or buy them.
Only those genuinely cruelty-free corporations are being chosen for the „BeneFaktorIndex® NO ANIMAL
TESTING“.
A BeneFaktorZerti kat® enables investors, for the very rst time, to speci cally invest where they identify
with a mission. The automatic donation* is usually pledged to the organization with the most clout and
impact on public opinion in that particular topic.
Due to the recurrent nature of the BeneFaktorZerti kat® donation*, all bene ciaries can plan with this money
longterm. Since many charitable organizations depend on donations, a reliable and recurrent donation is
highly welcome. Even more so because the raising of donations usually requires a lot of work, time and
money and the success of it all is never really sure beforehand. Most of the chosen bene ciaries are large
and well known charities and this is entirely intentional. It is important, that the money invested in any
BeneFaktorZerti kat® as well as the donation of each BeneFaktorZerti kat® has the highest possible e ect.
This is why we choose mainly large organizations: the bene ciaries must be able to realize large projects
with high impact in order to facilitate change.
To boost the impact of each BeneFaktorIndex®, the research of bene ciaries and other organizations in the
same eld are taken into account. Many organizations provide helpful information and assessments, which
are included in the BeneFaktorIndex® research wherever available and feasible. Of course only listed shares
can be incorporated in the BeneFaktorIndex®, any other form of stocks cannot be considered. And of
course by including a company’s stock one always „buys“ the whole company, not single brands or
business units. So it is necessary to evaluate the whole company - and this sometimes leads to exclusion,
maybe even despite perfectly tting single business units or individual brands.
After the initial phase of issue, which in Germany lies exclusively with comdirect (a brand of Commerzbank
AG), every BeneFaktorZerti kat® will be listed on the stock exchange (Germany: Börse Frankfurt Zerti kate,
Switzerland: BX Swiss). From the moment of listing every BeneFaktorZerti kat® will be available through
most banks or other nancial service providers.
* Note: Donations are being given freely and on a voluntary basis, there are no underlying contracts or other binding
arrangements with the bene ciaries.
Issue: May 2021 Page 3 / 5 Daubenthaler & Cie. GmbH
fi
fi
fi
fi
fi
fi
fi
fi
fi
fi
fi
fi
fi
fi
fi
fi
fi
fi
fi
fi
ffMay 2021 ADVERTISING / PUBLIC
OFFERING ONLY IN CH
FOR D PLEASE REFER TO
BACKGROUND INFO
IN GERMAN.
The team behind BeneFaktorZerti kat® and BeneFaktorIndex®
Issuer:
Every BeneFaktorZerti kat® is being issued as open-end index-tracker certi cate by Leonteq Securities AG,
Zürich (or subsidiaries) (www.leonteq.com)
Index administrator:
The BeneFaktorIndex®, the underlying basis of a BeneFaktorZerti kat® is being administered by LIXX
GmbH, Düsseldorf (www.lixxinnovation.com)
Sales and distribution:
During the initial phase of issue in Germany, retail sales lies exclusively with comdirect (a brand of
Commerzbank AG), Frankfurt (www.comdirect.de)
Idea, concept and index allocation:
Daubenthaler & Cie., Stuttgart (www.daubenthaler-cie.de)
We consider ourselves representatives of a new generation, who is keenly aware of the possibilities and the
leverage nancial markets can provide in nancing better solutions for tomorrow. We specialize in
developing ideas and products to make money and wealth a force for good and ensuring a healthy and
sustainable world for us and our fellow creatures.
To make sure products are easily identi able, only true BeneFaktor-products may carry this logo:
Our partners support us in our quest for integrating the public good in nancial products.
For this we would like to say „Thank You“ and "Danke Schön“,
especially in the name of those who bene t from our efforts.
Issue: May 2021 Page 4 / 5 Daubenthaler & Cie. GmbH
fi
fi
fi
fi
fi
fi
fi
fi
fiMay 2021 ADVERTISING / PUBLIC
OFFERING ONLY IN CH
FOR D PLEASE REFER TO
BACKGROUND INFO
IN GERMAN.
Disclaimer & Legal information:
The content of this publication is intended as marketing communication.
Investors will be provided products or services under the brand names BeneFaktorIndex® and BeneFaktorZerti kat® by
one or more legal entities that will be identi ed to clients pursuant to the contracts, agreements, o ering materials or
other documentation relevant to such products or services.
The information contained in this content does not constitute investment advice. This content is a nancial promotion
and is for general information purposes only and consequently may not be complete or accurate for your speci c
purposes. It is not intended to be an o er or solicitation, advice or recommendation, or the basis for any contract to
purchase or sell any security, or other instrument, or for Daubenthaler & Cie. GmbH to enter into or arrange any type of
transaction as a consequence of any information contained herein. It has been prepared without consideration of the
investment needs, objectives or nancial circumstances of any investor. This content does not identify all the risks
(direct and indirect) or other considerations which might be material to you when entering into a transaction. Before
making an investment decision, investors need to consider, with or without the assistance of an investment adviser,
whether the investments and strategies are suitable and appropriate, in light of their particular investment needs,
objectives and nancial circumstances. For detailed information on the related risks, please consult the legal
documentation (as applicable) such as annual and half-yearly reports, termsheets and/or management regulations,
sales prospectus and/or the key investor information. They are available through Leonteq Securities AG, Europaallee 36,
8004 Zürich, www.leonteq.com.
All statements of opinion re ect the current assessment of Daubenthaler & Cie. GmbH and are subject to change
without notice.
Forecasts are not a reliable indicator of future performance. Forecasts are based on assumptions, estimates, opinions
and hypothetical performance analysis, therefore actual results may vary, perhaps materially, from the results contained
here.
Past performance, [actual or simulated], is not a reliable indication of future performance.
The information contained in this content does not constitute a nancial analysis but quali es as marketing
communication. This marketing communication is neither subject to all legal provisions ensuring the impartiality of
nancial analysis nor to any prohibition on trading prior to the publication of nancial analyses.
This content and the information contained herein may only be distributed and published in jurisdictions in which such
distribution and publication is permissible in accordance with applicable law in those jurisdictions. Direct or indirect
distribution of this content is prohibited in the USA as well as to or for the account of US persons and persons residing
in the USA.
This content and the information contained herein may not be copied, published or redistributed without prior consent
of Daubenthaler & Cie.
BeneFaktorIndex®, BeneFaktorZerti kat® are registered trademarks with the DPMA,München. Registration of the
BeneFaktor-logo is ongoing. Their use has been licensed to LIXX GmbH and Leonteq Securities AG.
Daubenthaler & Cie. GmbH, Königstr. 27, 70173 Stuttgart, Germany - www.daubenthaler-cie.de
Date of release: May, 10th 2021
All rights reserved.
Issue: May 2021 Page 5 / 5 Daubenthaler & Cie. GmbH
fi
fi
fl
fi
fi
ff
fi
fi
fi
fi
ff
fi
fi
fiYou can also read
